Stockscreener 앱 받기
66.06
0.23%
0.15
시간 외 거래:
66.06
전일 마감가:
$65.91
열려 있는:
$66.45
하루 거래량:
10.64M
Relative Volume:
1.62
시가총액:
$25.76B
수익:
$4.30B
순이익/손실:
$571.50M
주가수익비율:
46.24
EPS:
1.4285
순현금흐름:
$570.80M
1주 성능:
-1.34%
1개월 성능:
+10.60%
6개월 성능:
-18.45%
1년 성능:
-12.87%
1일 변동 폭
$65.64
$66.87
1주일 범위
$65.20
$68.19
52주 변동 폭
$54.11
$93.25
덱스컴 Stock (DXCM) Company Profile
명칭
Dexcom Inc
전화
(858) 200-0200
주소
6340 SEQUENCE DRIVE, SAN DIEGO, CA
DXCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
66.06 | 25.71B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
125.45 | 217.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
95.61 | 142.48B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.20 | 135.04B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.63 | 126.25B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.66 | 49.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
덱스컴 Stock (DXCM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 개시 | Evercore ISI | In-line |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-09-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 개시 | Argus | Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-05-30 | 개시 | Goldman | Buy |
| 2025-04-10 | 개시 | Mizuho | Outperform |
| 2025-02-03 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-07-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 개시 | Redburn Atlantic | Neutral |
| 2024-03-12 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-04-17 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2023-01-26 | 개시 | Wolfe Research | Outperform |
| 2022-10-18 | 개시 | Barclays | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-15 | 개시 | Bernstein | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-02-03 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-18 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-28 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2021-01-06 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 재확인 | Piper Sandler | Overweight |
| 2020-05-14 | 개시 | Wells Fargo | Equal Weight |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2019-11-07 | 재확인 | Canaccord Genuity | Buy |
| 2019-11-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-10-23 | 개시 | Stifel | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-10-19 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-09-12 | 업그레이드 | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 재확인 | Canaccord Genuity | Buy |
| 2018-07-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
| 2018-05-03 | 재확인 | Canaccord Genuity | Buy |
| 2018-04-04 | 개시 | Goldman | Sell |
| 2018-04-04 | 개시 | Guggenheim | Neutral |
| 2018-03-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | 다운그레이드 | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 재확인 | Wedbush | Outperform |
모두보기
덱스컴 주식(DXCM)의 최신 뉴스
Will DexCom Inc. stock sustain high P E ratios2025 Key Lessons & Reliable Entry Point Trade Alerts - Улправда
DXCM STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Will DexCom Inc. stock benefit from sector rotationJuly 2025 Snapshot & Low Drawdown Trading Techniques - DonanımHaber
Levi & Korsinsky Reminds DexCom, Inc. Investors of the - GlobeNewswire
Investors in DexCom (NASDAQ:DXCM) have unfortunately lost 43% over the last three years - Yahoo Finance
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Meme Stocks: What sentiment indicators say about DexCom Inc. stockGap Down & Community Verified Trade Signals - Улправда
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom (DXCM) Fell Due to Modest Guidance - Insider Monkey
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Sendero Wealth Management LLC Has $4.54 Million Position in DexCom, Inc. $DXCM - MarketBeat
Thrivent Financial for Lutherans Lowers Holdings in DexCom, Inc. $DXCM - MarketBeat
Assenagon Asset Management S.A. Cuts Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom (NASDAQ:DXCM) Given New $78.00 Price Target at Mizuho - Defense World
DexCom, Inc. $DXCM Shares Bought by Gradient Investments LLC - Defense World
Investors who lost money on DexCom, Inc.(DXCM) should - GlobeNewswire
Key facts: Class action lawsuit filed against DexCom; Mizuho raises price target - TradingView — Track All Markets
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - The Globe and Mail
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
DexCom (DXCM): Mizuho Raises Price Target to $78, Maintains Outp - GuruFocus
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. InvestorsLead Plaintiff Deadline December 26, 2025 - ACCESS Newswire
Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Recover LossesContact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
DexCom, Inc. Deadline Approaching: Kessler Topaz Meltzer & - GlobeNewswire
DexCom, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - GlobeNewswire Inc.
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Join Class Action to Recover Losses from DexCom, Inc. (DXCM)Contact Levi & Korsinsky Before December 26, 2025 - ACCESS Newswire
Leerink Partners Adjusts Price Target on DexCom to $92 From $81, Maintains Outperform Rating - marketscreener.com
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors - GlobeNewswire
4 Reasons Why DexCom Could Be A Good Buy For 2026 (NASDAQ:DXCM) - Seeking Alpha
Shareholders of DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your RightsDXCM - Sahm
2025-12-15 | Class Action Lawsuit Filed Against DexCom, Inc. (DXCM)Recover LossesContact Levi & Korsinsky Before December 26, 2025 | NDAQ:DXCM | Press Release - Stockhouse
DXCM Deadline: DXCM Investors with Losses in Excess of $100K Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - marketscreener.com
DexCom Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Investors in DexCom, Inc. (DXCM): Protect Your RightsContact Levi & Korsinsky Before December 26, 2025 - Stockhouse
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT Bernstein - GlobeNewswire
Shareholders of DexCom, Inc. (DXCM): Protect Your Rights Before December 26, 2025Contact Levi & Korsinsky - Stockhouse
DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit - PR Newswire
Castleark Management LLC Invests $27.18 Million in DexCom, Inc. $DXCM - MarketBeat
2025-12-13 | Levi & Korsinsky Notifies DexCom, Inc. (DXCM) Shareholders of Class Action Lawsuit and December 26, 2025 Deadline | NDAQ:DXCM | Press Release - Stockhouse
Jim Cramer on DexCom: "It's Too Rich a Stock" - Finviz
Jim Cramer on DexCom: “It’s too rich a stock” - MSN
Jim Cramer on DexCom: “It’s Too Rich a Stock” - Insider Monkey
Bellevue Group AG Cuts Holdings in DexCom, Inc. $DXCM - MarketBeat
Shareholders of DexCom, Inc. Should Contact Levi & - GlobeNewswire
Key facts: DexCom faces class action lawsuit; Citigroup raises price target - TradingView — Track All Markets
DexCom, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit - Business Wire
덱스컴 (DXCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
1.11%
자본화:
|
볼륨(24시간):